Cargando…
Decision-Making on New Non-Drug Health Technologies by Hospitals and Health Authorities in Canada
INTRODUCTION: Unlike those for publicly funded drugs in Canada, coverage decision-making processes for non-drug health technologies (NDTs) are not well understood. OBJECTIVES: This paper aims to describe existing NDT decision-making processes in different healthcare organizations across Canada. METH...
Autores principales: | Stafinski, Tania, Deber, Raisa, Rhainds, Marc, Martin, Janet, Noseworthy, Tom, Bryan, Stirling, Menon, Devidas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Longwoods Publishing
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008692/ https://www.ncbi.nlm.nih.gov/pubmed/31629458 http://dx.doi.org/10.12927/hcpol.2019.25936 |
Ejemplares similares
-
The Introduction of New Non-Drug Health Technologies into Canadian Healthcare Institutions: Opportunities and Challenges
por: Stafinski, Tania, et al.
Publicado: (2019) -
Role of centralized review processes for making reimbursement decisions on new health technologies in Europe
por: Stafinski, Tania, et al.
Publicado: (2011) -
HTA decision-making for drugs for rare diseases: comparison of processes across countries
por: Stafinski, Tania, et al.
Publicado: (2022) -
The Medical Devices Special Access Program in Canada: A Scoping Study
por: Maier, Roland K., et al.
Publicado: (2018) -
Tracing the Decisions That Shaped the Development of MyChart, an Electronic Patient Portal in Alberta, Canada: Historical Research Study
por: Avdagovska, Melita, et al.
Publicado: (2020)